Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

sIL2R, soluble interleukin 2 receptor

Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still’s disease
D Y Chen, J L Lan, F J Lin, T Y Hsieh, M C Wen

Annals of the Rheumatic Diseases Oct 2004, 63 (10) 1300-1306; DOI: 10.1136/ard.2003.013680
Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse
J-S F Sanders, M G Huitma, C G M Kallenberg, C A Stegeman

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1484-1489; DOI: 10.1136/ard.2005.046219
Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab
A Kuuliala, R Nissinen, H Kautiainen, H Repo, M Leirisalo-Repo

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 26-29; DOI: 10.1136/ard.2004.034728